ProKidney

ProKidney halts one CKD cell therapy phase 3 trial considered surplus to FDA approval
Fierce Biotech
Tue, 09/3/24 - 11:19 am
ProKidney
cell therapy
chronic kidney disease
rilparencel
ProKidney drops $25.5M on North Carolina manufacturing site for cell therapy prospect
Fierce Pharma
Wed, 06/14/23 - 06:48 pm
ProKidney
drug manufacturing
North Carolina
kidney disease
Delaying type 1 diabetes progression: major trial readouts to watch in 2023
Clinical Trials Arena
Mon, 02/20/23 - 12:54 pm
clinical trials
type 1 diabetes
Provention Bio
Tzeild
Diamyd Medical
remygen
Imcyse
IMCY-0098
ProKidney
With $825M SPAC merger, ProKidney sets stage for phase 3 trial of kidney disease cell therapy
Fierce Biotech
Tue, 01/18/22 - 11:58 pm
ProKidney
SPACs
cell therapy
clinical trials
kidney disease